• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

管理急性心力衰竭综合征中伴有 ICD 电击的患者和程控心动过速治疗。

Managing patients with ICD shocks and programming tachycardia therapies during acute heart failure syndromes.

机构信息

UCLA Cardiac Arrhythmia Center, Ronald Reagan UCLA Medical Center, David Geffen School of Medicine at UCLA, A2-237 CHS, 650 Charles E. Young Drive South, Los Angeles, CA 90095-1679, USA.

出版信息

Heart Fail Rev. 2011 Sep;16(5):449-56. doi: 10.1007/s10741-011-9241-7.

DOI:10.1007/s10741-011-9241-7
PMID:21451976
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3139863/
Abstract

We review the pharmacologic, interventional and device programming treatment options for patients with implantable cardioverter-defibrillators who present with acute heart failure and implantable cardioverter-defibrillator shocks.

摘要

我们回顾了患有急性心力衰竭和植入式心脏除颤器电击的患者的药物治疗、介入治疗和设备程控治疗选择。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b0fd/3139863/2eab74a976fe/10741_2011_9241_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b0fd/3139863/75e16e284869/10741_2011_9241_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b0fd/3139863/5dadeb3f808f/10741_2011_9241_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b0fd/3139863/2eab74a976fe/10741_2011_9241_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b0fd/3139863/75e16e284869/10741_2011_9241_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b0fd/3139863/5dadeb3f808f/10741_2011_9241_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b0fd/3139863/2eab74a976fe/10741_2011_9241_Fig3_HTML.jpg

相似文献

1
Managing patients with ICD shocks and programming tachycardia therapies during acute heart failure syndromes.管理急性心力衰竭综合征中伴有 ICD 电击的患者和程控心动过速治疗。
Heart Fail Rev. 2011 Sep;16(5):449-56. doi: 10.1007/s10741-011-9241-7.
2
Prospective Randomized Evaluation of Implantable Cardioverter-Defibrillator Programming in Patients With a Left Ventricular Assist Device.前瞻性随机评估左心室辅助装置患者植入式心脏复律除颤器的程控。
J Am Heart Assoc. 2018 Feb 23;7(5):e007748. doi: 10.1161/JAHA.117.007748.
3
Should catheter ablation be the preferred therapy for reducing ICD shocks?: Ventricular tachycardia in patients with an implantable defibrillator warrants catheter ablation.导管消融术应成为减少植入式心律转复除颤器（ICD）电击的首选治疗方法吗？：植入式除颤器患者的室性心动过速需要进行导管消融。
Circ Arrhythm Electrophysiol. 2009 Dec;2(6):713-20; discussion 720. doi: 10.1161/CIRCEP.109.896571.
4
Active Arrhythmia Pattern: A Novel Predictor of ICD Shocks-A Subanalysis From the PARTITA Study.活动心律失常模式：ICD 电击的新预测因子——PARTITA 研究的一项亚分析。
Circ Arrhythm Electrophysiol. 2024 Jun;17(6):e012523. doi: 10.1161/CIRCEP.123.012523. Epub 2024 May 1.
5
Non-determinable defibrillation threshold and inefficacy of implantable cardioverter/defibrillator shocks due to defective connections of the defibrillator lead terminals in the device header port.由于除颤器导线端子在设备插头端口连接不良导致植入式心律转复除颤器（ICD）的除颤阈值无法确定以及电击无效。
Europace. 2007 Dec;9(12):1161-2. doi: 10.1093/europace/eum182. Epub 2007 Oct 3.
6
Long-Term Outcomes Among a Nationwide Cohort of Patients Using an Implantable Cardioverter-Defibrillator: UMBRELLA Study Final Results.全国植入式心脏复律除颤器患者队列的长期结局：UMBRELLA 研究最终结果。
J Am Heart Assoc. 2021 Jan 5;10(1):e018108. doi: 10.1161/JAHA.120.018108. Epub 2020 Dec 25.
7
Management of ventricular tachycardia in heart failure.心力衰竭中室性心动过速的管理
Methodist Debakey Cardiovasc J. 2013 Jan-Mar;9(1):20-5. doi: 10.14797/mdcj-9-1-20.
8
Should catheter ablation be the preferred therapy for reducing ICD shocks?: Ventricular tachycardia ablation versus drugs for preventing ICD shocks: role of adjuvant antiarrhythmic drug therapy.导管消融术是否应成为减少植入式心律转复除颤器（ICD）电击的首选治疗方法？：室性心动过速消融与药物预防ICD电击：辅助抗心律失常药物治疗的作用
Circ Arrhythm Electrophysiol. 2009 Dec;2(6):705-11; discussion 712. doi: 10.1161/CIRCEP.109.893628.
9
External implantable defibrillator as a bridge to reimplant after implantable cardioverter-defibrillator explant.体外植入式除颤器作为植入式心脏复律除颤器取出后再次植入的桥梁。
Europace. 2015 Nov;17(11):1726. doi: 10.1093/europace/euv305. Epub 2015 Oct 12.
10
Programming implantable cardioverter-defibrillator therapy zones to high ranges to prevent delivery of inappropriate device therapies in patients with primary prevention: results from the RISSY-ICD (Reduction of Inappropriate ShockS bY InCreaseD zones) trial.将植入式心律转复除颤器治疗区域程控至较高范围以预防一级预防患者不适当的设备治疗：RISSY-ICD（通过增加区域减少不适当电击）试验结果
Am J Cardiol. 2015 May 1;115(9):1235-43. doi: 10.1016/j.amjcard.2015.01.558. Epub 2015 Feb 12.

本文引用的文献

1
Neuraxial modulation for refractory ventricular arrhythmias: value of thoracic epidural anesthesia and surgical left cardiac sympathetic denervation.胸段硬膜外麻醉和外科左侧心脏交感神经切除术治疗难治性室性心律失常的神经轴调制作用。
Circulation. 2010 Jun 1;121(21):2255-62. doi: 10.1161/CIRCULATIONAHA.109.929703. Epub 2010 May 17.
2
The prognostic impact of shocks for clinical and induced arrhythmias on morbidity and mortality among patients with implantable cardioverter-defibrillators.植入式心脏复律除颤器患者的临床和诱导性心律失常所致休克对发病率和死亡率的预后影响。
Heart Rhythm. 2010 Jun;7(6):755-60. doi: 10.1016/j.hrthm.2010.02.039. Epub 2010 Mar 6.
3
Differences in effects of electrical therapy type for ventricular arrhythmias on mortality in implantable cardioverter-defibrillator patients.
不同电疗类型对植入式心脏复律除颤器患者室性心律失常死亡率的影响差异。
Heart Rhythm. 2010 Mar;7(3):353-60. doi: 10.1016/j.hrthm.2009.11.027. Epub 2009 Dec 2.
4
EHRA/HRS Expert Consensus on Catheter Ablation of Ventricular Arrhythmias: developed in a partnership with the European Heart Rhythm Association (EHRA), a Registered Branch of the European Society of Cardiology (ESC), and the Heart Rhythm Society (HRS); in collaboration with the American College of Cardiology (ACC) and the American Heart Association (AHA).欧洲心律协会（EHRA）/心律学会（HRS）室性心律失常导管消融专家共识：与欧洲心脏病学会（ESC）注册分支机构欧洲心律协会（EHRA）以及心律学会（HRS）合作制定；与美国心脏病学会（ACC）和美国心脏协会（AHA）协作。
Heart Rhythm. 2009 Jun;6(6):886-933. doi: 10.1016/j.hrthm.2009.04.030.
5
Amiodarone for the prevention of sudden cardiac death: a meta-analysis of randomized controlled trials.胺碘酮预防心脏性猝死：随机对照试验的荟萃分析。
Eur Heart J. 2009 May;30(10):1245-53. doi: 10.1093/eurheartj/ehp100. Epub 2009 Mar 31.
6
Effect of dronedarone on cardiovascular events in atrial fibrillation.决奈达隆对房颤心血管事件的影响。
N Engl J Med. 2009 Feb 12;360(7):668-78. doi: 10.1056/NEJMoa0803778.
7
Irrigated radiofrequency catheter ablation guided by electroanatomic mapping for recurrent ventricular tachycardia after myocardial infarction: the multicenter thermocool ventricular tachycardia ablation trial.心肌梗死后复发性室性心动过速的电解剖标测引导下的灌注射频导管消融：多中心Thermocool室性心动过速消融试验
Circulation. 2008 Dec 16;118(25):2773-82. doi: 10.1161/CIRCULATIONAHA.108.788604. Epub 2008 Dec 8.
8
Prognostic importance of defibrillator shocks in patients with heart failure.除颤电击对心力衰竭患者的预后重要性。
N Engl J Med. 2008 Sep 4;359(10):1009-17. doi: 10.1056/NEJMoa071098.
9
No benefit from defibrillation threshold testing in the SCD-HeFT (Sudden Cardiac Death in Heart Failure Trial).在心力衰竭试验（SCD-HeFT，即心脏性猝死心力衰竭试验）中，除颤阈值测试并无益处。
J Am Coll Cardiol. 2008 Aug 12;52(7):551-6. doi: 10.1016/j.jacc.2008.04.051.
10
Increased mortality after dronedarone therapy for severe heart failure.决奈达隆治疗严重心力衰竭后死亡率增加。
N Engl J Med. 2008 Jun 19;358(25):2678-87. doi: 10.1056/NEJMoa0800456.